Name | prednisone |
Synonyms | Cortan Colisone Bicortone Ancortone prednisone Prednisone 1,2-Dehydrocortisone 11,20-trione,17,21-hydroxy-pregna-4-diene-3 11,20-trione,17,21-dihydroxy-pregna-4-diene-3 1,4-pregnadiene-16-alpha,21-diol-3,11,20-trione 17-alpha,21-dihydroxypregna-1,4-diene-3,11,20-trione (8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione |
CAS | 53-03-2 |
EINECS | 200-160-3 |
InChI | InChI=1/C21H26O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-15,18,22,26H,3-4,6,8,10-11H2,1-2H3/t14?,15?,18?,19-,20-,21-/m0/s1 |
Molecular Formula | C21H26O5 |
Molar Mass | 358.43 |
Density | 1.1121 (rough estimate) |
Melting Point | 236-238°C(lit.) |
Boling Point | 410.86°C (rough estimate) |
Specific Rotation(α) | 169 º (c=0.5, dioxane) |
Flash Point | >200℃ |
Water Solubility | 115mg/L(25 ºC) |
Solubility | Practically insoluble in water, slightly soluble in ethanol (96 per cent) and in methylene chloride. It shows polymorphism (5.9). |
Vapor Presure | 1.51E-15mmHg at 25°C |
Appearance | Solid |
Color | White to Off-White |
Merck | 7722 |
BRN | 2065301 |
pKa | 12.36±0.60(Predicted) |
Storage Condition | 2-8°C |
Stability | Stable. Incompatible with strong oxidizing agents. |
Refractive Index | 170 ° (C=0.5, Dioxan |
Physical and Chemical Properties | White or off-white crystalline powder, no odor, slightly bitter taste. Practically insoluble in water, slightly soluble in ethanol (1:190) and chloroform (1:200). Mp233-235 C (decomposition), than the optical rotation [alpha] 25D 172 degrees (dioxane), the product of acetic acid solution at 240nm wavelength has the maximum absorption. |
Use | Commonly used in combination chemotherapy, can improve the general condition of patients, can also be used for acute leukemia and other tumors |
Hazard Symbols | Xn - Harmful |
Risk Codes | R63 - Possible risk of harm to the unborn child |
Safety Description | S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection. S45 - In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S16 - Keep away from sources of ignition. |
This product is 17a ,21-dihydroxyprogestin -1, 4-diene-3, 11, 20-trione. The content of C21H2605 shall be 97.0% ~ 102.0% calculated as dry product.
take this product, precision weighing, plus dioxane dissolution and quantitative dilution of about 5mg per lml solution, according to the law (General 0621), the specific rotation was 167 ° to 175 °.
take this product, precision weighing, plus ethanol dissolution and quantitative dilution to make a solution containing about 15ug per lml, according to UV-visible spectrophotometry (General 0401), the absorbance was measured at a wavelength of 240nm, and the absorption coefficient was 405 to 435.
take this product, precision weighing, adding mobile phase to dissolve and quantitatively dilute to make a solution containing about 0.5mg per lml as a test solution; Take 1ml for precision measurement, in a 100ml measuring flask, dilute to the scale with the mobile phase, shake well, and use as a control solution; Take the cortisone control, dissolve and quantitatively dilute with the mobile phase to make a solution containing about 5ug per 1ml, as a control solution. According to the chromatographic conditions under the content determination item, 20ul of each of the test solution, the control solution and the reference solution are accurately measured and injected into the human liquid chromatograph respectively, the chromatogram was recorded to 2.5 times of the retention time of the main component peak. If there are peaks in the chromatogram of the test solution that are consistent with the retention time of the pine peak in the chromatogram of the reference solution, the peak area shall be calculated according to the external standard method, and shall not exceed 0.5%; other single impurity peak area shall not be greater than 0.5 times (0.5%) of the main peak area of the control solution, and the sum of each impurity peak area shall not be greater than 1.5 times (1.5%) of the main peak area of the control solution. The peaks in the chromatogram of the test solution which were 0.01 times smaller than the main peak area of the control solution were ignored.
take about 0.5g of this product, dry at 105°C for 3 hours, and lose no more than 1.0% of weight (General rule 0831).
adrenocortical hormone drugs.
light shielding, sealed storage.